Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Maged S. Mahmoud"'
Autor:
Ebtesam M El-Gezawy, Eman Nasr Eldin, Wafaa S Mohamed, Maged S Mahmoud, Seham Ahmed Saied, Hanan Hareth Abd El-Latif, Maha Atwa Ibrahim
Publikováno v:
Saudi Journal of Kidney Diseases and Transplantation, Vol 24, Iss 4, Pp 688-695 (2013)
Tumor necrosis factor-alfa (TNF-α) gene polymorphism is supposed to have a significant influence on the incidence of acute rejection in renal transplantation. The monocyte chemoattractant protein-1 (MCP-1) is another factor supposed to modulate graf
Externí odkaz:
https://doaj.org/article/b17b41574d174e5195253817c810ed9e
Publikováno v:
Journal of Current Medical Research and Practice. 3:147
Autor:
Maged S. Mahmoud, Michio M. Kawano, Mohd S. Iqbal, Ken-ichiro Otsuyama, Toshikazu Gondo, Hideki Asaoku, Karim Shamsasenjan
Publikováno v:
European Journal of Haematology. 83:302-312
To evaluate nuclear factor-kappaB (NF-kappaB) activity in primary myeloma cells from myeloma patients, we confirmed that the expression levels of CD54 showed a good correlation with the levels of DNA binding activity for NF-kappaB in human myeloma ce
Autor:
Maged S. Mahmoud, Michio M. Kawano, Ken-ichiro Otsuyama, Saeid Abroun, Karim Shamsasenjan, Mohd S. Iqbal, Hideki Asaoku
Publikováno v:
International Journal of Hematology. 89:310-318
Human myeloma cells from about 10% of cases with multiple myeloma expressed CD33 and had monocytoid morphology with convoluted nuclei, and all these patients had no increase in serum CRP values. In CD33(+) myeloma cells as well as myeloma cell lines,
Autor:
Hideaki Ishikawa, Ryuichi Fujii, Naohiro Tsuyama, Michio M. Kawano, Maged S. Mahmoud, Shangqin Liu, Saeid Abroun, Fu-Jun Li
Publikováno v:
Leukemia & Lymphoma. 43:613-616
Multiple myeloma (MM) is a proliferative disorder of monoclonal plasma cells which accumulate in human bone marrow (BM). CD19 is a hallmark differentiation antigen of the B cell lineage and positively regulates antigen receptor signal transduction in
Publikováno v:
Leukemia & Lymphoma. 39:51-55
Multiple myeloma (MM) is a hematologic malignancy of human plasma cells, and myeloma cells can be classified into several subpopulations according to phenotypic differences, such as CD38 MPC-1- CD49e- immature, CD38 MPC-1+ CD49e- intermediate and CD3
Publikováno v:
Blood. 94:3551-3558
In multiple myeloma (MM), the cell surface protein, CD19, is specifically lost while it continues to be expressed on normal plasma cells. To examine the biological significance of loss of CD19 in human myeloma, we have generated CD19 transfectants of
Publikováno v:
Blood. 92:3887-3897
Recently, there has been an increasing interest in the expression pattern and biological significance of the CD45 molecule in myeloma cells. In this study, we have further defined the phenotypic pattern of CD45 expression on myeloma cells. Using a pa
Publikováno v:
British Journal of Haematology. 99:131-138
Myeloma cells consist of immature, intermediate and mature cells with respect to expression of VLA-5 (CD49e) and MPC-1 adhesion molecules. VLA-5 - MPC-1 - immature myeloma cells respond to interleukin 6 (IL-6) to proliferate in vitro, but VLA-5 + MPC
Autor:
Hanan Hareth Abd El-Latif, Maha Atwa Mohamed Ibrahim, Eman Nasr Eldin, Seham Ahmed Saied, E El-Gezawy, Maged S. Mahmoud, Wafaa S Mohamed
Publikováno v:
Saudi Journal of Kidney Diseases and Transplantation, Vol 24, Iss 4, Pp 688-695 (2013)
Tumor necrosis factor-alfa (TNF-α) gene polymorphism is supposed to have a significant influence on the incidence of acute rejection in renal transplantation. The monocyte chemoattractant protein-1 (MCP-1) is another factor supposed to modulate graf